Fundraising FoxRemeditex Ventures
Venture capitalDallas · Seed
Find your way into Remeditex Ventures
What they invest in
from 2 of 2 portfolio companiesBiotech ×1Healthtech ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathmiRagen Therapeutics is a biopharmaceutical company developing monoclonal antibodies and other engineered protein therapeutics targeting specific receptors (IGF-1R, FcRn, and TSHR) for autoimmune and rare diseases including thyroid eye disease, Graves' disease, and various autoimmune conditions.
BiotechBoulder, US
William S. Marshall(Executive Officer, Director)Jason A. Leverone(Executive Officer)inDavid Rodman(Executive Officer)Stephen Mahoney(President, Chief Executive Officer and Director)Thomas Beetham(Chief Operating Officer)inRadhika Tripuraneni(Chief Medical Officer)in
Co-investorsBrace PharmaBroadview VenturesMC Healthcare VenturesRidgeback CapitalAtlas VentureBoulder Ventures+1 more
HealthtechCambridge, US
Adam Rosenberg(Executive Officer, Director)in
BoardBruce Booth(Director)inKees Been(Director)Samantha Singer(Director)
Co-investorsGV (Google Ventures)Hatteras Venture PartnersThird Point VenturesAtlas VentureJJDC
Exits · 1
1 IPOsmiRagen TherapeuticsNASDAQ: VRDN
Frequently asked questions
- What stage does Remeditex Ventures invest at?
- Remeditex Ventures invests at the Seed stage.
- What sectors does Remeditex Ventures focus on?
- Remeditex Ventures focuses on Biotech.
- Where is Remeditex Ventures located?
- Remeditex Ventures is headquartered in Dallas, US.
Images
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.